Oncology Virtual Partnering: 2-5 March, 2021

During four days of face to face online meetings, leading researchers, top biotechs and biopharmaceutical companies will meet, network and partner to accelerate oncology pipelines and bring new treatment options to patients worldwide.

Inova Software BIO
In partnership with Evaluate

About this conference

Find the best early-stage biotechs

Oncology is one of the most challenging areas for research and development, but there are critical junctures where the right environment is crucial for success - and where partnering can help bring the best science forward.

At Inova, our aim is to facilitate the bridge between science and business. Inova and Biotechnology Innovation Organization (BIO), in partnership with Evaluate, are organizing this Oncology Virtual Partnering Event. Through online one-to-one meetings taking place 2 - 5 March, researchers, biotechs and biopharmaceutical companies will discuss the latest research from oncology congresses, pitch ideas and partner to prioritize the most promising research efforts.

This event will leverage Inova and Biotechnology Innovation Organization (BIO)’s biopharma industry expertise, leading digital networking platform and years of experience organizing partnering events to connect scientific and business communities for the benefit of patients worldwide.

03
Mar

Calculating Risk and Return in Oncology Development Webinar

9AM — 10 am (ET) / 3 pm — 4 pm (CET)

What is a virtual Partnering Event?

It’s a conference of virtual face-to-face meetings. All meetings are online instead of at a physical location.

Increase your company visibility during the event

Free Company Presentations

If you are an attending biotech, biopharma, medtech or digital health company, you benefit from free visibility with a company presentation (max. 6 minutes video or PDF slideshow).

Submit a presentation

Live Sessions

Can’t make it to a live session? Register anyway and we will send your the recording.

03
Mar

Calculating Risk and Return in Oncology Development Webinar

9AM — 10 am (ET) / 3 pm — 4 pm (CET)

Webinar recording

Watch recording

Calculating Risk and Return in Oncology Development Webinar

9AM — 10 am (ET) / 3 pm — 4 pm (CET)

In this session, we investigate macro trends and forecasts in oncology using proprietary EvaluatePharma and Evaluate Omnium metrics, and offer perspectives from our work on the best frameworks and methodologies to quantify risk and return in highly dynamic oncology markets.

This live session will be animated by:

  • Dr. Paul Verdin, Head of Custom Solutions at Evaluate
  • Henry Barling, Senior Oncology Analyst at Evaluate

Watch recording

23
Feb

Events Preview & Platform Demo Webinar

10AM — 11 am (ET) / 4 pm — 5 pm (CET)

Webinar recording

Watch recording

Events Preview & Platform Demo Webinar

10AM — 11 am (ET) / 4 pm — 5 pm (CET)

Get an insider’s preview of Inova & BIO’s upcoming Virtual Partnering events in March: Oncology Virtual Partnering 2-5 March and Immunology Virtual Partnering 9-12 March

Our team from Inova, BIO and Evaluate will animate a live session on:

  • Who’s attending: company and asset profiles
  • A walk-through of Inova’s best-in-class One-on-One Partnering™ platform
  • The ins & outs of Virtual Partnering and how to make the most of the event
  • Webinar sessions during the events
  • Q&A

Watch recording

Who will attend?

The Oncology Virtual Partnering Event is open to any organization that provides product, knowledge or technologies that can help advance the oncology pipeline. The types of treatments being developed range from chemotherapy, small molecules and oral drug formulations all the way to cancer vaccines, immune cell therapies, cytokine modulation and monoclonal antibodies.

Pharma & Biotech

Academia

Medical Research

Services

Clinical Trials

Diagnostic & Biomarkers

Carrier Systems & Formulation

Financing

The Virtual Partnering Event will bring these stakeholders together to pursue:

Potential R&D collaborations

Early stage discovery collaboration

Drug repurposing

Biological markers and diagnostic tests

Adjuvants, carrier systems, and formulation technologies

Tools for research projects

Animal and in-silico models

Funding and investors

Partners for clinical trials

HalioDx

“HalioDx, a leader in immuno-oncology diagnostics and CRO partner for oncologists and BioPharma is coming to Oncology Virtual Partnering to present our first-in-class multi-omic based programs that draw on our expertise and focus on immuno-oncology. The targeted one-on-one meetings specifically focused on oncology will allow us to identify the innovative partners for these collaborations. ”

Prescient Therapeutics

“Prescient Therapeutics is excited to participate in Oncology Virtual Partnering to discuss our novel next-generation CAR-T/CAR-NK technology platform - OmniCAR. The targeted one-on-one meetings and easy-to-use partnering system allow us to discuss our modular, controllable CAR-T technology with partners looking to add post-infusion safety and control to their own CAR-T/NK programs. ”

Timeline

Registration for the Oncology Virtual Partnering event opens on 18 January. Then, our partnering platform, One-on-One Partnering, will open on 15 February so that participants will have a little over 3 weeks to make connections and request online meetings. On 2 March the virtual partnering starts with online scheduled meetings for four days through 5 March.

18 January 2021

Registration opens

Registration for the Virtual
Partnering Event starts.

15 February 2021

Platform is open

Participants can begin
sending meeting requests.

2-5 March 2021

Virtual Conference

Scheduled meetings will
take place online.

About the Virtual Partnering Platform

This event will leverage Inova and BIO's matchmaking platform, One-on-One Partnering™, that has been at the heart of major international biopharmaceutical conventions since 2015. It’s the leading partnering system that facilitates thousands of face-to-face meetings at dozens of biopharma conferences worldwide including the BIO International Convention, BIO Digital and BIO Asia. For instance, in the weeks before the BIO International Convention, 4,000 biopharma companies connect online, list their technologies and capabilities, and request meetings with potential partners. By the time the Convention opens thousands of relevant meetings are scheduled – almost 50,000 at BIO Convention 2019 alone.